Alliance Medical Products receives Good Manufacturing Practice (GMP) Certification by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for sterile liquids, solids, devices and implants.

IRVINE, CA February 14, 2011 – ALLIANCE MEDICAL PRODUCTS ("AMP”) announced today the Medicines and Healthcare Regulatory Agency (MHRA) has issued a Good Manufacturing Practice (GMP) Certificate following an audit of the manufacturing site conducted in December 2010. The certificate covers sterile liquids, solids, devices and implants manufactured in any of AMP’s eight aseptic suites and ancillary manufacturing suites.

"We are extremely pleased with the results of the recent audits of our Irvine, California sterile manufacturing facility,” said Juan Valdes, President and CEO. “We have an excellent history of successful audits with regulatory agencies on the state, national and international level. The recent certification by the MHRA further demonstrates AMP’s commitment to maintain our quality and manufacturing systems to the highest global standards."

The MHRA is an Executive Agency of the UK Department of Health, responsible for ensuring the safety, quality and efficacy of medical devices and pharmaceutical products. MHRA experts assess all applications to ensure they meet the required standards and follow up with a system of inspection, testing and safety monitoring.

ALLIANCE MEDICAL PRODUCTS, INC. is a full service cGMP, FDA, MHRA and ISO13485 drug, device and combination product contract manufacturer providing developmental, clinical and commercial contract manufacturing services to large and small organizations. AMP specializes in difficult to manufacture formulations that include solutions, suspensions, emulsions, sterile ointments and gels with the capability to fill an array of container closures including; vials, dropper tip bottles, screw cap bottles, cartridges and tubes. AMP has extensive manufacturing capabilities which include five high volume automated aseptic filling suites and three semi-automated low volume aseptic filling suites. In addition to its manufacturing capabilities, AMP maintains state of the art micro and analytical laboratories, and the capability to provide stability services meeting all ICH guidelines.

If you’d like more information about AMP, or to schedule a meeting, please contact Steve Tulk at 949-454-4582 or email Steve at This e-mail address is being protected from spambots. You need JavaScript enabled to view it

IRVINE, November 15, 2010 – ALLIANCE MEDICAL PRODUCTS ("AMP”) announced today, at the AAPS Annual Meeting and Exposition,  the U.S. Food and Drug Administration (FDA) has granted approval to manufacture a certain commercially available ophthalmic product using the company's high speed dropper bottle filling line.

“The FDA's approval to manufacture another commercial product in our facility further demonstrates AMP's ability to bring our customers products successfully from clinical thru commercial manufacture," said Juan Valdes, President and CEO.  "Over the years, we have enjoyed repeated success in transferring our customers products to our 54,000 square foot facility in Irvine California and scaling those products up to full commercial manufacture."

The product is approved for immediate manufacture using AMP's high speed Capmatic Patriot dropper bottle filling line. The line is capable of filling 5,000 to 30,000 units per shift with container sizes ranging from 3mL to 30mL.

Steve Tulk, Vice President of Business Development and Kevin O’Brien, Director of Sales, will be available to discuss the company’s capabilities during the exposition.

“We are very pleased to be participating in this premier industry conference,” said Valdes. “We look forward to the opportunity to discuss our capabilities in person and further develop relationships with new and existing customers."

ALLIANCE MEDICAL PRODUCTS, INC. is a full service cGMP, FDA and ISO13485 drug, device and combination product contract manufacturer providing developmental, clinical and commercial contract manufacturing services to large and small organizations. AMP specializes in difficult to manufacture formulations that include solutions, suspensions, emulsions, sterile ointments and gels with the capability to fill an array of container closures including vials, dropper tip bottles, screw cap bottles, cartridges and squeeze tubes. AMP has extensive manufacturing capabilities which include four high volume automated aseptic filling suites and three semi-automated low volume aseptic filling suites. In addition to its manufacturing capabilities, AMP maintains state of the art micro and analytical laboratories, and the capability to provide stability services meeting all ICH guidelines.

The AAPS Annual Meeting and Exposition takes place on

• Sunday November 14th, 2010 through Thursday November 18th, 2010
• at the Morial Convention Center, New Orleans, LA.
• This event marks AMP’s eighth consecutive appearance at the AAPS Annual Meeting.

If you’d like more information about AMP, or to schedule a meeting, please contact Steve Tulk at 949-454-4582 or email Steve at This e-mail address is being protected from spambots. You need JavaScript enabled to view it